Published in N Engl J Med on December 28, 1995
Safety Study of Lactobacillus Administered Vaginally to Healthy Women | NCT00537576
Preterm birth among African American and white women: a multilevel analysis of socioeconomic characteristics and cigarette smoking. J Epidemiol Community Health (2003) 6.82
Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev (1998) 5.36
Temporal dynamics of the human vaginal microbiota. Sci Transl Med (2012) 4.58
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS (2008) 4.21
Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ (2008) 3.45
Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev (2005) 3.20
Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One (2008) 3.01
Systemic diseases caused by oral infection. Clin Microbiol Rev (2000) 2.97
Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS One (2012) 2.79
Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl Environ Microbiol (2008) 2.73
Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect Immun (1998) 2.71
Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis (2004) 2.67
Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One (2010) 2.62
The human vaginal bacterial biota and bacterial vaginosis. Interdiscip Perspect Infect Dis (2009) 2.56
Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex Transm Infect (2005) 2.55
The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG (2011) 2.41
Gram-positive anaerobic cocci. Clin Microbiol Rev (1998) 2.34
Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J Clin Microbiol (2009) 2.29
The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome (2014) 2.24
Exploring the diversity of Gardnerella vaginalis in the genitourinary tract microbiota of monogamous couples through subtle nucleotide variation. PLoS One (2011) 2.06
Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics (2010) 2.04
Assessing the effects of welfare reform policies on reproductive and infant health. Am J Public Health (1999) 1.97
Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol (2012) 1.94
Factors linked to bacterial vaginosis in nonpregnant women. Am J Public Health (2001) 1.86
Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis. Sex Transm Infect (2010) 1.80
Temporal and spatial variation of the human microbiota during pregnancy. Proc Natl Acad Sci U S A (2015) 1.79
Adverse birth outcomes in United Republic of Tanzania--impact and prevention of maternal risk factors. Bull World Health Organ (2007) 1.78
Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am J Reprod Immunol (2010) 1.74
Gynecologic conditions and bacterial vaginosis: implications for the non-pregnant patient. Infect Dis Obstet Gynecol (2000) 1.74
Vaginal douching: evidence for risks or benefits to women's health. Epidemiol Rev (2002) 1.71
Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol (2011) 1.69
Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners. BMC Microbiol (2007) 1.66
Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev (2007) 1.65
A longitudinal study of vaginal douching and bacterial vaginosis--a marginal structural modeling analysis. Am J Epidemiol (2008) 1.63
Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J Nutr (2009) 1.61
Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID. Sex Transm Dis (2010) 1.59
Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women. J Clin Microbiol (2002) 1.59
Gram stain method shows better sensitivity than clinical criteria for detection of bacterial vaginosis in surveillance of pregnant, low-income women in a clinical setting. Infect Dis Obstet Gynecol (1998) 1.57
Risk of Adverse Pregnancy Outcomes among Women Practicing Poor Sanitation in Rural India: A Population-Based Prospective Cohort Study. PLoS Med (2015) 1.51
Association between Lactobacillus species and bacterial vaginosis-related bacteria, and bacterial vaginosis scores in pregnant Japanese women. BMC Infect Dis (2007) 1.51
Exploratory comparison of vaginal glycogen and Lactobacillus levels in premenopausal and postmenopausal women. Menopause (2015) 1.49
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. J Clin Invest (2011) 1.44
Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections. Clin Infect Dis (2015) 1.44
Recent advances in understanding the microbiology of the female reproductive tract and the causes of premature birth. Infect Dis Obstet Gynecol (2010) 1.43
Effectiveness of Home Visits in Pregnancy as a Public Health Measure to Improve Birth Outcomes. PLoS One (2015) 1.38
Influence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study. BMJ (1999) 1.37
Menstrual Hygiene Practices, WASH Access and the Risk of Urogenital Infection in Women from Odisha, India. PLoS One (2015) 1.36
Is bacterial vaginosis a sexually transmitted infection? Sex Transm Infect (2001) 1.36
A prospective cohort study of pregnancy risk factors and birth outcomes in Aboriginal women. CMAJ (2004) 1.35
The vaginal microbiota of pregnant women who subsequently have spontaneous preterm labor and delivery and those with a normal delivery at term. Microbiome (2014) 1.35
Antibiotic susceptibility of Atopobium vaginae. BMC Infect Dis (2006) 1.30
Comparative study of vaginal Lactobacillus phages isolated from women in the United States and Turkey: prevalence, morphology, host range, and DNA homology. Clin Diagn Lab Immunol (2001) 1.28
Women's experiences of general practitioner management of their vaginal symptoms. Br J Gen Pract (1996) 1.27
Use of species-directed 16S rRNA gene PCR primers for detection of Atopobium vaginae in patients with bacterial vaginosis. J Clin Microbiol (2004) 1.26
Identification and genotyping of bacteria from paired vaginal and rectal samples from pregnant women indicates similarity between vaginal and rectal microflora. BMC Infect Dis (2009) 1.26
Partner violence during pregnancy: prevalence, effects, screening, and management. Int J Womens Health (2010) 1.25
Bacterial vaginosis, vaginal flora patterns and vaginal hygiene practices in patients presenting with vaginal discharge syndrome in The Gambia, West Africa. BMC Infect Dis (2005) 1.24
Composition of the vaginal microbiota in women of reproductive age--sensitive and specific molecular diagnosis of bacterial vaginosis is possible? PLoS One (2013) 1.21
Differences in vaginal microbiome in African American women versus women of European ancestry. Microbiology (2014) 1.20
Understanding vaginal microbiome complexity from an ecological perspective. Transl Res (2012) 1.19
Metabolic signatures of bacterial vaginosis. MBio (2015) 1.18
A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection. Infect Dis Obstet Gynecol (2001) 1.17
The vaginal microbiome during pregnancy and the postpartum period in a European population. Sci Rep (2015) 1.17
Preterm birth due to maternal infection: Causative pathogens and modes of prevention. Eur J Clin Microbiol Infect Dis (2006) 1.16
Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. Am J Obstet Gynecol (2007) 1.16
Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis. J Clin Microbiol (2005) 1.16
Bacterial vaginosis (BV) candidate bacteria: associations with BV and behavioural practices in sexually-experienced and inexperienced women. PLoS One (2012) 1.16
Phylogeny-based rapid identification of mycoplasmas and ureaplasmas from urethritis patients. J Clin Microbiol (2002) 1.15
Lack of effectiveness of syndromic management in targeting vaginal infections in pregnancy in Entebbe, Uganda. Sex Transm Infect (2006) 1.15
The complex vaginal flora of West African women with bacterial vaginosis. PLoS One (2011) 1.13
America's Health Centers: reducing racial and ethnic disparities in perinatal care and birth outcomes. Health Serv Res (2004) 1.13
Comparative genomic analyses of 17 clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consistent with subspeciation into genovars. J Bacteriol (2012) 1.13
The microbiota of the vagina and its influence on women's health and disease. Am J Med Sci (2012) 1.11
Quantitative microbiologic models for preterm delivery. J Clin Microbiol (2003) 1.10
Antibody-based detection and inhibition of vaginolysin, the Gardnerella vaginalis cytolysin. PLoS One (2009) 1.10
Bacterial Vaginosis. Curr Infect Dis Rep (2000) 1.09
A prospective study of risk factors for bacterial vaginosis in HIV-1-seronegative African women. Sex Transm Dis (2008) 1.08
Elucidation of the Molecular Mechanisms of Action of the Natural Antimicrobial Peptide Subtilosin Against the Bacterial Vaginosis-associated Pathogen Gardnerella vaginalis. Probiotics Antimicrob Proteins (2011) 1.08
Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J Clin Microbiol (2005) 1.08
Urogenital infections in women: can probiotics help? Postgrad Med J (2003) 1.07
BVBlue test for diagnosis of bacterial vaginosis. J Clin Microbiol (2003) 1.07
Prevalence of bacterial vaginosis and correlation of clinical to Gram stain diagnostic criteria in low risk pregnant women. Eur J Epidemiol (1999) 1.07
More than meets the eye: associations of vaginal bacteria with gram stain morphotypes using molecular phylogenetic analysis. PLoS One (2013) 1.07
On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections. Expert Rev Anti Infect Ther (2013) 1.06
Pyrosequencing of the genital microbiotas of HIV-seropositive and -seronegative women reveals Lactobacillus iners as the predominant Lactobacillus Species. Appl Environ Microbiol (2010) 1.04
Spermicidal activity of the safe natural antimicrobial peptide subtilosin. Infect Dis Obstet Gynecol (2008) 1.04
The burden of bacterial vaginosis: women's experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS One (2013) 1.03
Preterm delivery and low birth weight--a dire legacy. N Engl J Med (1995) 1.02
Correlates of cervical Mycoplasma genitalium and risk of preterm birth among Peruvian women. Sex Transm Dis (2010) 1.02
Free glycogen in vaginal fluids is associated with Lactobacillus colonization and low vaginal pH. PLoS One (2014) 1.02
Bacterial vaginosis and human immunodeficiency virus infection. AIDS Res Ther (2007) 1.01
Diversity of cervicovaginal microbiota associated with female lower genital tract infections. Microb Ecol (2011) 1.01
Analysis of vaginal acetic acid in patients undergoing treatment for bacterial vaginosis. J Clin Microbiol (2004) 1.01
Racial differences in cervical cytokine concentrations between pregnant women with and without bacterial vaginosis. J Reprod Immunol (2008) 1.01
Human α-amylase present in lower-genital-tract mucosal fluid processes glycogen to support vaginal colonization by Lactobacillus. J Infect Dis (2014) 1.01
NATURAL ANTIMICROBIALS AND THEIR ROLE IN VAGINAL HEALTH: A SHORT REVIEW. Int J Probiotics Prebiotics (2008) 1.00
Rapid detection of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum organisms in genitourinary samples by PCR-microtiter plate hybridization assay. J Clin Microbiol (2003) 1.00
Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front Physiol (2015) 1.00
Associations of LINE-1 DNA Methylation with Preterm Birth in a Prospective Cohort Study. J Dev Orig Health Dis (2012) 0.99
Degradation, foraging, and depletion of mucus sialoglycans by the vagina-adapted Actinobacterium Gardnerella vaginalis. J Biol Chem (2013) 0.99
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol (1991) 20.49
Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med (1983) 11.15
Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis (1997) 6.64
Enteropathogenic Escherichia coli of classic serotypes associated with infant diarrhea: epidemiology and pathogenesis. Epidemiol Rev (1984) 5.98
A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med (1988) 5.32
Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med (2000) 5.15
Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med (1975) 4.99
Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity. Science (2011) 4.72
Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA (1986) 4.62
Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol (1988) 4.23
Summary of an international workshop on typhoid fever. Rev Infect Dis (1986) 4.21
Application of computer-assisted interviews to sexual behavior research. Am J Epidemiol (1999) 3.82
A review of premature birth and subclinical infection. Am J Obstet Gynecol (1992) 3.76
Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol (1986) 3.67
Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol (2003) 3.50
Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol (2000) 3.44
Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis (1999) 3.38
The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis (1993) 3.32
Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet Gynecol (1990) 3.28
Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers. J Clin Microbiol (1996) 3.19
Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis (1991) 3.17
Comparison of methods for diagnosing bacterial vaginosis among pregnant women. J Clin Microbiol (1989) 3.06
Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis (1992) 2.93
Self-collection of vaginal swabs for the detection of Chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents. Sex Transm Dis (2001) 2.86
The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. Obstet Gynecol (1991) 2.78
From the National Institute of Allergy and Infectious Diseases. Summary of a workshop on enteropathogenic Escherichia coli. J Infect Dis (1983) 2.71
Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA (1995) 2.71
Earth, motherhood, and the intrauterine device. Fertil Steril (1992) 2.67
Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA (1982) 2.55
Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. J Infect Dis (1997) 2.55
Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect Immun (1997) 2.44
Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet (1982) 2.38
Criteria for diagnosis and grading of salpingitis. Obstet Gynecol (1983) 2.37
A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1991) 2.33
The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol (1992) 2.32
Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors. Am J Obstet Gynecol (1977) 2.31
Characteristics of three vaginal flora patterns assessed by gram stain among pregnant women. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1992) 2.27
Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers. Infect Immun (1992) 2.23
Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med (2001) 2.23
Phenotypic and genotypic characterization of nosocomial Staphylococcus aureus isolates from trauma patients. J Clin Microbiol (1998) 2.22
Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. J Infect Dis (1990) 2.19
Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis (1982) 2.17
Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol (1996) 2.16
The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol (1992) 2.15
The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol (1993) 2.12
Venezuelan equine encephalitis. Adv Vet Sci Comp Med (1974) 2.12
Association between vaginal douching and acute pelvic inflammatory disease. JAMA (1990) 2.11
Bacterial colonization of the vagina during pregnancy in four ethnic groups. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1996) 2.10
Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. J Infect Dis (1995) 2.10
Suicide attempters in Madurai. J Indian Med Assoc (1971) 2.09
Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J Infect Dis (1994) 2.03
Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans. Infect Immun (1981) 2.03
Vesicular stomatitis virus replication in human leukocyte cultures: enhancement by phytohemagglutinin. Science (1966) 2.03
Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA (1990) 2.02
Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol (2000) 2.02
Nibbling versus gorging: metabolic advantages of increased meal frequency. N Engl J Med (1989) 2.01
High prevalence of cervical dysplasia in STD clinic patients warrants routine cytologic screening. Am J Public Health (1980) 1.99
Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR. J Infect Dis (1992) 1.94
Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae. J Infect Dis (1993) 1.93
Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial. Clin Infect Dis (2011) 1.92
Confirming positive results of nucleic acid amplification tests (NAATs) for Chlamydia trachomatis: all NAATs are not created equal. J Clin Microbiol (2005) 1.88
Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis. Am J Surg Pathol (1990) 1.88
High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: a pilot study. Am J Trop Med Hyg (1996) 1.86
Clinical characteristics of bacterial vaginosis among women testing positive for fastidious bacteria. Sex Transm Infect (2008) 1.83
Management of genital herpes infection in pregnancy. Obstet Gynecol (1988) 1.80
A study of suicide in Madurai. J Indian Med Assoc (1966) 1.79
The clinical diagnosis of genital ulcer disease in men. Clin Infect Dis (1997) 1.79
Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis (2000) 1.79
Complement and C3-proactivator levels in children with protein-calorie malnutrition and effect of dietary treatment. Lancet (1973) 1.79
The epidemiology of acquired immunodeficiency syndrome among heterosexuals. JAMA (1988) 1.78
Curved anaerobic bacteria in bacterial (nonspecific) vaginosis and their response to antimicrobial therapy. J Infect Dis (1983) 1.77
Vaginal Bacteroides species are associated with an increased rate of preterm delivery among women in preterm labor. J Infect Dis (1991) 1.77
Wegener's granulomatosis: patient-reported effects of disease on health, function, and income. Arthritis Rheum (1998) 1.74
Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. J Clin Microbiol (2001) 1.73
Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol (1996) 1.72